MODERATOR(S)
Zain Siddiqui, MD, FRCPC - Penn State Cancer Institute
Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
08:00am - 08:05am ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
-
08:05am - 08:10am ETSpeaker: Abraham Wu, MD - Memorial Sloan Kettering Cancer Center, New York
-
08:10am - 08:15am ET
-
08:15am - 08:20am ET
Long-Term Survival and Biomarker-Based Exploratory Analysis of Nimotuzumab Combined with SIB-IMRT in Locally Advanced Esophageal Cancer: Insights from a Phase II Clinical Trial
Speaker: Chun Han, MD - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang -
08:20am - 08:25am ET
Proton vs. Photon EBRT for Hepatocellular Carcinoma: A Multi-Institutional Individual Patient Data Analysis Using Propensity Score Weighting
Speaker: Ted Yanagihara, MD, PhD - University of North Carolina, Chapel Hill -
08:25am - 08:30am ET
Long-Term Outcomes of Image-Guided Proton Therapy for Treatment-Naïve Solitary Hepatocellular Carcinoma Amenable to Surgical Resection or Radiofrequency Ablation: A Pooled Analysis of a Phase II Trial and Prospective Cohort
Speaker: Hiromitsu Iwata, MD, PhD - Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya -
08:35am - 08:55am ETSpeaker: Zain Siddiqui, MD, FRCPC - Penn State Cancer Institute, Kingston
-
08:55am - 09:00am ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles